Quick Answer
NORTHWEST BIOTHERAPEUTICS INC reported Cash And Cash Equivalents At Carrying Value of $2.18 million for the year ending 2024.
- NORTHWEST BIOTHERAPEUTICS INC showed an increase of +2.3% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
- This data is from NORTHWEST BIOTHERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 1996 to 2024 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2024: $2.18 million | Fiscal year 2023: $2.13 million | Fiscal year 2022: $6.97 million | Fiscal year 2021: $15.17 million | Fiscal year 2020: $9.98 million | Fiscal year 2019: $372.0 thousand | Fiscal year 2018: $22.22 million | Fiscal year 2017: $117.0 thousand | Fiscal year 2016: $6.87 million | Fiscal year 2015: $21.81 million | Fiscal year 2014: $13.39 million | Fiscal year 2013: $18.50 million | Fiscal year 2012: $7.35 million | Fiscal year 2011: $24.0 thousand | Fiscal year 2010: $153.0 thousand | Fiscal year 2009: $65.0 thousand | Fiscal year 1996: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: